|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets | |||||||||||||
| Cash | |||||||||||||
| Due from related party | |||||||||||||
| Accounts receivable | |||||||||||||
| Inventory | |||||||||||||
| Other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property, plant and equipment | |||||||||||||
| Leasehold improvements | |||||||||||||
| Accumulated Depreciations | |||||||||||||
| Property and equipment, net | |||||||||||||
| Operating lease - right-of-use asset | |||||||||||||
| Non-compete agreement, net | |||||||||||||
| Intellectual property | |||||||||||||
| Other intangible assets | |||||||||||||
| Accumulated Amortization | |||||||||||||
| Security deposit | |||||||||||||
| Total other assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||||
| Current liabilities and total liabilities | |||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||
| Due to related party | |||||||||||||
| Unearned revenue | |||||||||||||
| Promissory notes – related parties | |||||||||||||
| Operating lease - current liability | |||||||||||||
| Other current liabilities | |||||||||||||
| Related Party | |||||||||||||
| Total other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Operating lease - long-term liability | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders’ deficit | |||||||||||||
| Members’ deficit | |||||||||||||
| Series A convertible preferred stock, par value $.001; 5,000,000 shares authorized; 161 and 150 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | |||||||||||||
| Common stock; $0.001 par value; 295,000,000 shares authorized; 28,280,868 and 28,019,624 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' deficit | |||||||||||||
| Total stockholders’ deficit | |||||||||||||
| Total Liabilities and Stockholders’ Deficit | |||||||||||||
Loading...
